| Date Filed | Type | Description |
| 08/21/2023 |
8-K
| Other Events Interactive Data |
| 08/10/2023 |
8-K
| Quarterly results |
| 07/17/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/12/2023 |
8-K
| Other Events Interactive Data |
| 05/30/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 05/24/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Underwriting Agreement, by and among Phathom Pharmaceuticals, Inc. and Jefferies LLC and Evercore Group L.L.C., as representatives of the several underwriters named therein",
"Opinion of Latham & Watkins LLP",
"Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock Florham Park, N.J., May 23, 2023 - Phathom Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. In addition, Phathom intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the total number of the shares of its common stock offered in the public offering. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Phathom intends to use the net proceeds from the proposed offer...",
"Phathom Pharmaceuticals Announces Pricing of Public Offering of Common Stock Florham Park, N.J., May 23, 2023 - Phathom Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today the pricing of its underwritten public offering of 11,125,000 shares of its common stock at a price to the public of $11.75 per share. The gross proceeds to Phathom from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $130.7 million. In addition, Phathom has granted the underwriters a 30-day option to purchase up to an additional 1,668,750 shares of common stock at the public offering price, less underwriting discounts and commiss..." |
|
| 05/23/2023 |
8-K
| Other Events Interactive Data |
| 05/10/2023 |
8-K
| Quarterly results |
| 04/04/2023 |
8-K
| Other Events Interactive Data |
| 02/28/2023 |
8-K
| Quarterly results |
| 02/09/2023 |
8-K
| Other Events Interactive Data |
| 01/09/2023 |
8-K
| Other Events Interactive Data |
| 01/03/2023 |
8-K
| Other Events Interactive Data |
| 11/09/2022 |
8-K
| Quarterly results |
| 11/01/2022 |
8-K
| Quarterly results |
| 10/24/2022 |
8-K
| Quarterly results |
| 09/29/2022 |
8-K
| Quarterly results |
| 09/26/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/04/2022 |
8-K
| Quarterly results |
| 08/02/2022 |
8-K
| Quarterly results |
| 05/27/2022 |
8-K
| Quarterly results |
| 05/25/2022 |
8-K
| Quarterly results |
| 05/10/2022 |
8-K
| Quarterly results |
| 05/04/2022 |
8-K
| Quarterly results |
| 05/03/2022 |
8-K
| Other Events Interactive Data |
| 04/26/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/28/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/14/2022 |
8-K
| Other Events Interactive Data |
| 03/01/2022 |
8-K
| Quarterly results |
| 02/09/2022 |
8-K
| Other Events Interactive Data |
| 01/25/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/08/2021 |
8-K
| Quarterly results |
| 10/18/2021 |
8-K
| Results of Operations and Financial Condition, Other Events Interactive Data |
| 09/27/2021 |
8-K
| Quarterly results |
|